JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120616

2,3-Butanedione 2-monoxime (BDM), Non-selective myosin ATPase inhibitor

Be the first to review this product! Submit a review

|

(3 Publications)

MW 101.1 g/mol. Non-selective myosin ATPase inhibitor (Ki = 5 mM at myosin II). Potent Kv2.1 (DRK1) and L-Type Ca2+ channel inhibitor (Ki and IC50 values are 10.7 nM and 5.8 mM, respectively). Blood-brain barrier permeable. Inhibits muscle contraction.
1 Images
Chemical Structure - 2,3-Butanedione 2-monoxime (BDM), Non-selective myosin ATPase inhibitor (AB120616)
  • Chemical Structure

Lab

Chemical Structure - 2,3-Butanedione 2-monoxime (BDM), Non-selective myosin ATPase inhibitor (AB120616)

2D chemical structure image of ab120616, 2,3-Butanedione 2-monoxime (BDM), Non-selective myosin ATPase inhibitor

Key facts

CAS number

57-71-6

Form

Solid

form

Molecular weight

101.1 g/mol

Molecular formula

C<sub>4</sub>H<sub>7</sub>NO<sub>2</sub>

Nature

Synthetic

Solubility

Soluble in water to 100 mM

Biological description

Non-selective myosin ATPase inhibitor (Ki = 5 mM at myosin II). Potent Kv2.1 (DRK1) and L-Type Ca2+ channel inhibitor (Ki and IC50 values are 10.7 nM and 5.8 mM, respectively). Blood-brain barrier permeable. Inhibits muscle contraction.

IUPAC Name

2,3-Butanedione monoxime

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

American journal of physiology. Regulatory, integrative and comparative physiology 323:R616-R627 PubMed36094447

2022

K4 channels in isolectin B4 muscle dorsal root ganglion neurons of rats with experimental peripheral artery disease: effects of bradykinin B1 and B2 receptors.

Applications

Unspecified application

Species

Unspecified reactive species

Qin Li,Lu Qin,Jianhua Li

eLife 11: PubMed35373735

2022

Precise in vivo functional analysis of DNA variants with base editing using ACEofBASEs target prediction.

Applications

Unspecified application

Species

Unspecified reactive species

Alex Cornean,Jakob Gierten,Bettina Welz,Juan Luis Mateo,Thomas Thumberger,Joachim Wittbrodt

Cell systems 12:670-687.e10 PubMed34043964

2021

Cell states beyond transcriptomics: Integrating structural organization and gene expression in hiPSC-derived cardiomyocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Kaytlyn A Gerbin,Tanya Grancharova,Rory M Donovan-Maiye,Melissa C Hendershott,Helen G Anderson,Jackson M Brown,Jianxu Chen,Stephanie Q Dinh,Jamie L Gehring,Gregory R Johnson,HyeonWoo Lee,Aditya Nath,Angelique M Nelson,M Filip Sluzewski,Matheus P Viana,Calysta Yan,Rebecca J Zaunbrecher,Kimberly R Cordes Metzler,Nathalie Gaudreault,Theo A Knijnenburg,Susanne M Rafelski,Julie A Theriot,Ruwanthi N Gunawardane
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com